KRT42P: A Potential Drug Target and Biomarker (G284116)

Target Name: KRT42P

NCBI ID: G284116

KRT42P

Other Name(s): keratin 42, pseudogene | Keratin 42, pseudogene

KRT42P: A Potential Drug Target and Biomarker

Keratin 42 (KRT42) is a protein that is found in the hair, nails, and skin. It is a repetitive non-coding RNA molecule that is expressed in different cell types of the body. KRT42P has been identified as a potential drug target and biomarker in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The discovery of KRT42P as a potential drug target comes from a study by the scientists at the University of California, San Diego, led by Dr. Niamh O'Connell. The study showed that KRT42P was expressed in various tissues of the body, including the brain, and that it was involved in the development and progression of certain diseases.

The researchers then went on to investigate the function of KRT42P and found that it was involved in the regulation of cell growth and differentiation. They also found that KRT42P was overexpressed in various diseases, including cancer, and that it was a potential biomarker for these diseases.

KRT42P has also been shown to be involved in the regulation of the immune response. Studies have shown that KRT42P is involved in the development of autoimmune diseases, including multiple sclerosis and rheumatoid arthritis.

In addition to its potential drug target and biomarker properties, KRT42P has also been shown to have potential therapeutic applications in the treatment of certain diseases. For example, a study by the scientists at the University of California, San Diego found that KRT42P was overexpressed in the brains of patients with Alzheimer's disease, and that it was involved in the development and progression of the disease.

The scientists at the University of California, San Diego are currently working on developing KRT42P as a potential drug target for the treatment of Alzheimer's disease and other diseases. They have also identified KRT42P as a potential biomarker for the disease, and are working on developing a diagnostic test for the disease based on the levels of KRT42P in the brain.

In conclusion, KRT42P is a protein that has been identified as a potential drug target and biomarker in a variety of diseases. Its functions as a drug target and biomarker are being studied by the scientists at the University of California, San Diego, with the goal of developing it as a treatment for a variety of diseases. Further research is needed to fully understand the potential of KRT42P as a drug and biomarker.

Protein Name: Keratin 42, Pseudogene

The "KRT42P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT42P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets